[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617329":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":24,"locations":28,"responsibleParty":49,"collaborators":24,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":24,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":24,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":24,"overallStatus":31,"whyStopped":24,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"University of Sao Paulo","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ayahuasca","EXPERIMENTAL","oral ayahuasca",[13],"Drug: Ayahuasca",{"label":15,"type":16,"description":17,"interventionNames":18},"esketamine","ACTIVE_COMPARATOR","oral esketamine",[19],"Drug: Esketamine",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG",[9],null,{"type":22,"name":26,"description":17,"armGroupLabels":27,"otherNames":24},"Esketamine",[15],[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Hospital das Clínicas da FMRP-USP","RECRUITING","Ribeirão Preto","São Paulo","14049900","Brazil","BR",{"type":38,"coordinates":39},"Point",[40,41],-47.81028,-21.1775,{"lat":41,"lon":40},[44],{"name":45,"role":46,"phone":47,"phoneExt":24,"email":48},"Rafael Guimarães Santos","CONTACT","5516997721969","banisteria@gmail.com",{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Rafael Guimarães dos Santos","PhD","100617329","phase-2-ayahuasca-esketamine-and-ptsd-100617329",false,"NCT07317206","Ayahuasca, Esketamine and PTSD","Effects of Single Dose of Ayahuasca or Esketamine on Posttraumatic Stress Disorder: a Randomized, Double-blinded Study","Inclusion Criteria:\n\n* posttraumatic stress disorder\n\nExclusion Criteria:\n\n* psychiatric and other medical comorbidities","ALL","18 Years","65 Years",{"count":64,"type":65},10,"ESTIMATED","INTERVENTIONAL",[68],"PHASE2","Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.",[71],"Posttraumatic Stress Disorder (PTSD)","2025-12-19",{"date":74,"type":75},"2026-01-05","ACTUAL",{"date":77,"type":75},"2025-12-20",{"date":79,"type":65},"2026-07",{"name":5,"class":6},1]